STOCK TITAN

Shareholder in RMD (NYSE: RMD) plans 50-share Form 144 sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder in RMD filed a Form 144 notice to sell 50 shares of common stock through Fidelity Brokerage Services LLC, with an aggregate market value of 13000.00, on or about 02/04/2026 on the NYSE. The 50 shares were acquired as restricted stock vesting on 11/11/2021 as compensation from the issuer. Over the past three months, the same account has sold 50 shares of common stock on 12/01/2025 for gross proceeds of 12208.00 and another 50 shares on 01/02/2026 for gross proceeds of 12087.50.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for RMD disclose?

The Form 144 shows a planned sale of 50 RMD common shares. The shareholder intends to sell 50 shares through Fidelity Brokerage Services LLC on or about February 4, 2026, with an aggregate market value of $13,000. The shares will be sold on the NYSE.

How many RMD shares are covered by this Form 144 notice?

The notice covers 50 shares of RMD common stock. These 50 shares have an aggregate market value of $13,000 based on the figures provided and are proposed to be sold on the NYSE through Fidelity Brokerage Services LLC around February 4, 2026.

How were the RMD shares in the Form 144 originally acquired?

The 50 RMD shares were acquired through restricted stock vesting. The acquisition date is November 11, 2021, and the nature of the transaction is listed as restricted stock vesting from the issuer, with compensation indicated as the form of payment for the shares.

What recent RMD stock sales has this shareholder made?

The shareholder sold 100 RMD shares in the past three months. They sold 50 common shares on December 1, 2025, for gross proceeds of $12,208 and another 50 common shares on January 2, 2026, for gross proceeds of $12,087.50, according to the disclosure.

How many RMD shares are outstanding in this Form 144 disclosure?

The filing lists 145,678,401 RMD common shares outstanding. This figure appears alongside the planned sale of 50 shares and provides context on the issuer’s total common stock base at the time reflected in the Form 144 filing.
Resmed

NYSE:RMD

RMD Rankings

RMD Latest News

RMD Latest SEC Filings

RMD Stock Data

38.90B
145.22M
0.79%
64.76%
5.81%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
SAN DIEGO